春立医疗：关于与私募基金合作投资的进展公告

Group 1 - The company, Chunli Medical, announced its investment in the establishment of the Nanchang Defu Phase IV Equity Investment Fund Partnership, contributing 50 million RMB as a limited partner, which represents 9.2105% of the fund's total shares [2] - The fund has completed the necessary business registration procedures and has obtained a business license from the Nanchang Market Supervision Administration [2]